• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MC-38腺癌肿瘤浸润淋巴细胞:肿瘤接种后细胞毒性与肿瘤收获时间的相关性

MC-38 adenocarcinoma tumor infiltrating lymphocytes: correlation of cytotoxicity with time of tumor harvest after tumor inoculation.

作者信息

Lafreniere R, Borkenhagen K, Bryant L D

机构信息

Division of Surgical Oncology, University of Calgary, Alberta, Canada.

出版信息

J Surg Oncol. 1990 Jan;43(1):8-12. doi: 10.1002/jso.2930430104.

DOI:10.1002/jso.2930430104
PMID:2404160
Abstract

Tumor infiltrating lymphocytes (TILs) are capable of mediating significant tumor regressions in vitro and in vivo in animal systems. In humans, however, many TIL cell lines are not cytotoxic in vitro, and clinical trials thus far have been less than encouraging. We attempted to correlate TIL cytotoxicity with time of tumor harvest and TIL cell surface antigenic expression. TILs harvested from early MC-38 adenocarcinoma tumors (days 9 and 20 post-tumor implantation), demonstrated significantly higher cytotoxicity against a variety of tumor targets compared to older TILs (days 31 and 37). The younger TILs had a higher expression of the Lyt-1 (Helper T cells), asialo GM1 (NK and T cells), and 49H.8 (NK cells) antigens. Comparison with the MCA-102 sarcoma, a tumor that does not lead to cytotoxic TILs, revealed a low expression of the Lyt-1 antigen on their cell surface. We conclude that TILs cytotoxicity is time-dependent and may be dependent on the presence of Lyt-1+ cells in the overall TIL population of cells.

摘要

肿瘤浸润淋巴细胞(TILs)在动物系统中能够在体外和体内介导显著的肿瘤消退。然而,在人类中,许多TIL细胞系在体外没有细胞毒性,并且迄今为止的临床试验效果并不理想。我们试图将TIL的细胞毒性与肿瘤收获时间以及TIL细胞表面抗原表达相关联。与较老的TIL(肿瘤植入后第31天和第37天)相比,从早期MC-38腺癌肿瘤(肿瘤植入后第9天和第20天)收获的TIL对多种肿瘤靶标的细胞毒性显著更高。较年轻的TIL中Lyt-1(辅助性T细胞)、脱唾液酸GM1(自然杀伤细胞和T细胞)和49H.8(自然杀伤细胞)抗原的表达更高。与不会产生细胞毒性TIL的MCA-102肉瘤进行比较,发现其细胞表面Lyt-1抗原的表达较低。我们得出结论,TIL的细胞毒性具有时间依赖性,并且可能取决于整个TIL细胞群体中Lyt-1+细胞的存在。

相似文献

1
MC-38 adenocarcinoma tumor infiltrating lymphocytes: correlation of cytotoxicity with time of tumor harvest after tumor inoculation.MC-38腺癌肿瘤浸润淋巴细胞:肿瘤接种后细胞毒性与肿瘤收获时间的相关性
J Surg Oncol. 1990 Jan;43(1):8-12. doi: 10.1002/jso.2930430104.
2
Tumor-infiltrating lymphocytes cultured in recombinant interleukin-2: enhancement of growth, cytotoxicity, and phenotypic expression of cytotoxic T-cell antigens by cyclophosphamide given intravenously prior to tumor harvest.在重组白细胞介素-2中培养的肿瘤浸润淋巴细胞:在收获肿瘤前静脉注射环磷酰胺可增强其生长、细胞毒性以及细胞毒性T细胞抗原的表型表达。
J Biol Response Mod. 1989 Jun;8(3):238-51.
3
In vivo administration of picibanil (OK-432) prior to tumor harvest leads to an enhancement of tumor-infiltrating lymphocyte (TIL) cytotoxicity.在收获肿瘤之前对小鼠进行体内注射沙培林(OK-432),可增强肿瘤浸润淋巴细胞(TIL)的细胞毒性。
J Surg Oncol. 1990 Feb;43(2):117-22. doi: 10.1002/jso.2930430211.
4
In vitro and in vivo antitumor properties of a T-cell clone generated from murine tumor-infiltrating lymphocytes.从小鼠肿瘤浸润淋巴细胞产生的T细胞克隆的体外和体内抗肿瘤特性。
J Biol Response Mod. 1990 Oct;9(5):499-511.
5
Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.人肾细胞癌中CD4 +和CD8 +肿瘤浸润淋巴细胞的细胞溶解活性特征
Cancer Res. 1990 Apr 15;50(8):2363-70.
6
Generation of MC-38 adenocarcinoma tumor-specific tumor infiltrating lymphocytes by murine anti-CD3 antibody and recombinant interleukin-2.通过鼠抗CD3抗体和重组白细胞介素-2产生MC-38腺癌肿瘤特异性肿瘤浸润淋巴细胞
Mol Biother. 1991 Mar;3(1):26-33.
7
Synergistic actions of picibanil (OK-432) on recombinant interleukin-2 induction of tumor-infiltrating lymphocyte expansion, cytotoxicity, and phenotypic differentiation.沙培林(OK-432)对重组白细胞介素-2诱导肿瘤浸润淋巴细胞扩增、细胞毒性及表型分化的协同作用。
J Biol Response Mod. 1990 Feb;9(1):53-60.
8
Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcoma.效应前体T淋巴细胞对进行性同基因小鼠肉瘤反应的表型分析及细胞机制
Cancer Res. 1990 Jul 15;50(14):4371-6.
9
Solid-phase anti-CD3 antibody activation of murine tumor-infiltrating lymphocytes.鼠肿瘤浸润淋巴细胞的固相抗CD3抗体激活
Cancer Res. 1990 May 1;50(9):2587-92.
10
Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.同基因小鼠肉瘤已形成转移灶的过继性T细胞治疗中免疫相互作用的细胞基础。
J Immunol. 1988 Aug 1;141(3):1047-53.

引用本文的文献

1
Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression.给予低剂量联合抗 CTLA4、抗 CD137 和抗 OX40 进入小鼠肿瘤或肿瘤引流淋巴结附近可诱导全身性肿瘤消退。
Cancer Immunol Immunother. 2018 Jan;67(1):47-60. doi: 10.1007/s00262-017-2059-y. Epub 2017 Sep 13.